US J&J’s 1-dose shot cleared, giving US 3rd COVID-19 vaccine
Here's how severe weather is affecting Covid-19 vaccinations in these states
The frigid temperatures, snow and ice that have devastated parts of the country are having an impact on Covid-19 vaccinations, delaying deliveries and appointments for shots. © David Ryder/Getty Images A skier makes their way down a hill on February 13, 2021 in Seattle, Washington. A large winter storm dropped heavy snow across the region.
WASHINGTON (AP) — The U.S. is getting a third vaccine to prevent COVID-19, as the Food and Drug Administration on Saturday cleared a Johnson & Johnson shot that works with just one dose instead of two.
Health experts are anxiously awaiting a one-and-done option to help speed vaccinations, as they race against a virus that already has killed more than 510,000 people in the U.S. and is mutating in increasingly worrisome ways.
The FDA said J&J’s vaccine offers strong protection against what matters most: serious illness, hospitalizations and death. One dose was 85% protective against the most severe COVID-19 illness, in a massive study that spanned three continents — protection that remained strong even in countries such as South Africa, where the variants of most concern are spreading.
Overnight Health Care: Biden visits Pfizer vaccine manufacturing plant in Michigan | Snow delays 6 million doses | Israeli study provides new evidence in one-dose debate
Welcome to Friday's Overnight Health Care. At the end of a long week, it was nice to have an (at least somewhat) hopeful take on what this summer might look like from The Atlantic. Follow us on Twitter: @NateWeixel, @jessiehellmann and @PeterSullivan4. Today we have President Biden visiting a Pfizer factory, snow storms delaying a lot of vaccine doses, and new evidence that maybe just one shot is needed (though Dr. Fauci pushed back). Let'sFollow us on Twitter: @NateWeixel, @jessiehellmann and @PeterSullivan4.
“The more vaccines that have high efficacy that we can get into play, the better,” Dr. Anthony Fauci, the top U.S. infectious disease expert, said ahead of the FDA’s ruling.
Shipments of a few million doses to be divided among states could begin as early as Monday. By the end of March, J&J has said it expects to deliver 20 million doses to the U.S., and 100 million by summer.
J&J also is seeking authorization for emergency use of its vaccine in Europe and from the World Health Organization. Worldwide, the company aims to produce about 1 billion doses globally by the end of the year. On Thursday, the island nation of Bahrain became the first to clear its use.
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.
Biden to announce ‘historic partnership’: Merck will help make Johnson & Johnson coronavirus vaccine, officials say .
The administration brokered the arrangement amid concerns about Johnson & Johnson production delays The officials, who spoke on the condition of anonymity to discuss a matter that has not been announced, said they began scouring the country for additional manufacturing capacity after they realized in the first days of the administration that Johnson & Johnson had fallen behind in vaccine production. They soon sought to broker a deal with Merck, one of the world’s largest vaccine makers, which had tried and failed to develop its own coronavirus vaccine.